EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Breast cancer risk characteristics of women undergoing whole‐breast ultrasound screening versus mammography alone

Brian L Sprague iD, Laura Ichikawa, Joanna Eavey, Kathryn P Lowry iD, Garth Rauscher, Ellen S O'Meara, Diana L Miglioretti, Shuai Chen iD, Janie M Lee, Natasha K Stout, Jeanne S Mandelblatt iD, Nila Alsheik und 4 weitere

Cancer · 15.08.2023 · 129 (16) · 2456-2468

DOI: 10.1002/cncr.34768 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, online erschienen am 12.06.2023. Verfasst von Brian L Sprague und 15 weiteren Autor:innen. Beteiligte Einrichtung: Office of Health Promotion Research, Department of Surgery, University of Vermont Larner College of Medicine, Burlington, Vermont, USA. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, AHRQ HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There are no consensus guidelines for supplemental breast cancer screening with whole‐breast ultrasound. However, criteria for women at high risk of mammography screening failures (interval invasive cancer or advanced cancer) have been identified. Mammography screening failure risk was evaluated among women undergoing supplemental ultrasound screening in clinical practice compared with women undergoing mammography alone.

Methods

A total of 38,166 screening ultrasounds and 825,360 screening mammograms without supplemental screening were identified during 2014–2020 within three Breast Cancer Surveillance Consortium (BCSC) registries. Risk of interval invasive cancer and advanced cancer were determined using BCSC prediction models. High interval invasive breast cancer risk was defined as heterogeneously dense breasts and BCSC 5‐year breast cancer risk ≥2.5% or extremely dense breasts and BCSC 5‐year breast cancer risk ≥1.67%. Intermediate/high advanced cancer risk was defined as BCSC 6‐year advanced breast cancer risk ≥0.38%.

Results

A total of 95.3% of 38,166 ultrasounds were among women with heterogeneously or extremely dense breasts, compared with 41.8% of 825,360 screening mammograms without supplemental screening ( p < .0001). Among women with dense breasts, high interval invasive breast cancer risk was prevalent in 23.7% of screening ultrasounds compared with 18.5% of screening mammograms without supplemental imaging (adjusted odds ratio, 1.35; 95% CI, 1.30–1.39); intermediate/high advanced cancer risk was prevalent in 32.0% of screening ultrasounds versus 30.5% of screening mammograms without supplemental screening (adjusted odds ratio, 0.91; 95% CI, 0.89–0.94).

Conclusions

Ultrasound screening was highly targeted to women with dense breasts, but only a modest proportion were at high mammography screening failure risk. A clinically significant proportion of women undergoing mammography screening alone were at high mammography screening failure risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsFemaleHumansEarly Detection of CancerMammographyRisk FactorsUltrasonography, MammaryMass ScreeningBreast Density

Stichwörter der Autor:innen

Breast Cancer Surveillance Consortiumbreast cancermammographyrisk factorsscreeningultrasound

Autor:innen und Institutionen

  • Office of Health Promotion Research, Department of Surgery, University of Vermont Larner College of Medicine, Burlington, Vermont, USA.
  • Department of Radiology, University of Vermont Larner College of Medicine, Burlington, Vermont, USA.
  • University of Vermont Cancer Center, University of Vermont Larner College of Medicine, Burlington, Vermont, USA.
  • Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.
  • Department of Radiology, University of Washington and Seattle Cancer Care Alliance, Seattle, Washington, USA.
  • Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, Illinois, USA.

ORCID-Profile: Brian L Sprague, Kathryn P Lowry, Shuai Chen, Jeanne S Mandelblatt

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • AHRQ HHS
  • Agency for Healthcare Research and Quality
  • National Institute of General Medical Sciences
  • National Cancer Institute
  • Patient-Centered Outcomes Research Institute

Zitieren

APA

Sprague, B. L., Ichikawa, L., Eavey, J., Lowry, K. P., Rauscher, G., O'Meara, E. S., Miglioretti, D. L., Chen, S., Lee, J. M., Stout, N. K., Mandelblatt, J. S., Alsheik, N., Herschorn, S. D., Perry, H., Weaver, D. L., & Kerlikowske, K. (2023). Breast cancer risk characteristics of women undergoing whole‐breast ultrasound screening versus mammography alone. Cancer, 129(16), 2456-2468. https://doi.org/10.1002/cncr.34768

Vancouver

Sprague BL, Ichikawa L, Eavey J, Lowry KP, Rauscher G, O'Meara ES, et al. Breast cancer risk characteristics of women undergoing whole‐breast ultrasound screening versus mammography alone. Cancer. 2023;129(16):2456-2468. doi:10.1002/cncr.34768

BibTeX
@article{Sprague2023,
  author = {Sprague, Brian L and Ichikawa, Laura and Eavey, Joanna and Lowry, Kathryn P and Rauscher, Garth and O'Meara, Ellen S and Miglioretti, Diana L and Chen, Shuai and Lee, Janie M and Stout, Natasha K and Mandelblatt, Jeanne S and Alsheik, Nila and Herschorn, Sally D and Perry, Hannah and Weaver, Donald L and Kerlikowske, Karla},
  title = {Breast cancer risk characteristics of women undergoing whole‐breast ultrasound screening versus mammography alone},
  journal = {Cancer},
  year = {2023},
  volume = {129},
  number = {16},
  pages = {2456--2468},
  doi = {10.1002/cncr.34768}
}
Kostenlos starten →